Ginkgo Bioworks Holdings, Inc. - Laporan Laba Rugi (TTM)

Ginkgo Bioworks Holdings, Inc.
US ˙ NYSE

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Ginkgo Bioworks Holdings, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 77 100 133 197 314 438 539 528 478 390 326 315 251 209 184 218 227 237 231
Change (%) 29.96 33.60 48.32 58.98 39.61 23.05 -2.08 -9.51 -18.36 -16.42 -3.36 -20.17 -17.00 -11.67 18.24 4.17 4.57 -2.78
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 16 39 56 77 130 191 238 241 204 141 95 78 54 41 36 42 45 47 48
Change (%) 151.82 43.52 36.39 68.53 47.60 24.45 0.99 -15.11 -30.88 -32.46 -18.60 -30.42 -24.39 -10.71 13.93 7.25 6.39 2.32
% of Revenue 20.36 39.46 42.39 38.98 41.32 43.69 44.19 45.57 42.75 36.19 29.25 24.64 21.48 19.57 19.78 19.06 19.62 19.96 21.01
Gross Operating Profit 61 60 77 120 184 247 301 287 273 249 231 237 197 168 148 176 182 190 182
Change (%) -1.21 27.13 57.09 52.89 33.98 21.96 -4.51 -4.82 -9.01 -7.33 2.93 -16.82 -14.98 -11.91 19.30 3.45 4.13 -4.05
% of Revenue 79.64 60.54 57.61 61.02 58.68 56.31 55.81 54.43 57.25 63.81 70.75 75.36 78.52 80.43 80.22 80.94 80.38 80.04 78.99
SG&A 38 50 75 94 863 1,279 1,683 2,088 1,403 1,080 713 382 351 310 302 252 237 216 199
Change (%) 29.65 51.33 24.59 821.57 48.23 31.58 24.07 -32.81 -23.04 -33.98 -46.41 -8.21 -11.73 -2.41 -16.68 -5.76 -8.96 -7.64
% of Revenue 49.97 49.85 56.47 47.44 274.97 291.96 312.20 395.58 293.73 276.88 218.70 121.29 139.45 148.31 163.86 115.47 104.45 90.94 86.40
R&D 160 189 209 226 1,150 1,414 1,652 1,860 1,053 892 746 641 581 554 544 465 424 359 278
Change (%) 18.37 10.45 8.12 409.09 22.96 16.84 12.62 -43.41 -15.29 -16.35 -14.05 -9.44 -4.51 -1.81 -14.63 -8.75 -15.45 -22.55
% of Revenue 208.42 189.84 156.94 114.40 366.32 322.65 306.36 352.35 220.35 228.64 228.85 203.54 230.90 265.67 295.32 213.22 186.78 151.01 120.30
OpEx 214 278 340 396 2,142 2,884 3,573 4,189 2,660 2,113 1,548 1,101 985 903 889 758 706 628 526
Change (%) 30.14 22.42 16.44 440.41 34.63 23.88 17.24 -36.50 -20.58 -26.73 -28.89 -10.49 -8.37 -1.52 -14.75 -6.88 -11.00 -16.33
% of Revenue 278.75 279.15 255.80 200.82 682.62 658.29 662.75 793.51 556.83 541.71 474.91 349.47 391.84 432.58 482.29 347.75 310.85 264.57 227.71
Operating Income -137 -178 -207 -199 -1,828 -2,446 -3,034 -3,661 -2,182 -1,723 -1,222 -786 -734 -694 -705 -540 -479 -391 -295
Change (%) 30.25 16.19 -4.02 818.74 33.78 24.03 20.67 -40.39 -21.06 -29.06 -35.70 -6.61 -5.42 1.53 -23.38 -11.34 -18.38 -24.56
% of Revenue -178.75 -179.15 -155.80 -100.82 -582.62 -558.29 -562.75 -693.51 -456.83 -441.71 -374.91 -249.47 -291.84 -332.58 -382.29 -247.75 -210.85 -164.57 -127.71
Interest Expense -2 -2 -2 -5 -2 -2 -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -5.49 -5.28 136.72 -53.05 -20.02 -25.18 -37.18 -88.12 -0.00 -0.00 -0.00 -12.26 -0.00 -0.00 -0.00 1.08 -0.00 -0.00
% of Revenue -3.11 -2.26 -1.60 -2.56 -0.76 -0.43 -0.26 -0.17 -0.02 -0.03 -0.03 -0.03 -0.04 -0.04 -0.05 -0.04 -0.04 -0.04 -0.04
Net Income -127 -175 -200 -276 -1,830 -2,347 -2,962 -3,530 -2,105 -1,719 -1,224 -857 -893 -854 -898 -651 -547 -472 -315
Change (%) 38.38 14.43 37.82 562.30 28.25 26.20 19.19 -40.37 -18.32 -28.82 -30.01 4.23 -4.37 5.14 -27.46 -16.00 -13.70 -33.23
% of Revenue -165.16 -175.87 -150.64 -139.98 -583.12 -535.66 -549.38 -668.69 -440.63 -440.87 -375.48 -271.96 -355.08 -409.12 -486.98 -298.78 -240.94 -198.84 -136.56

Source: Capital IQ

Other Listings
MX:DNA
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista